China Widens Probe of Sexual Bribes and Glaxo Execs

July 16 (Bloomberg) -- China is investigating at least four multinational drugmakers as it widens its probe of GlaxoSmithKline Plc, according to a lawyer in Hong Kong whose firm advises companies on cross-border anti-corruption. Olivia Sterns reports on Bloomberg Television's "Market Makers." (Source: Bloomberg)
El-Erian: ECB Is Over-Optimistic About QE
13:24 - Bloomberg View Columnist Mohamed El-Erian discusses the ECB’s government bond buying program. He speaks on “In The Loop.” El-Erian’s opinions are his own. (Source: Bloomberg)
  • El-Erian: Jobs Report Encourages Gradual Fed Rate Hike
  • Apple Watch Debuts on March 9
  • Apple to Join Dow Jones, Replaces AT&T